Ken O'Flynn
Written
959. Deputy Ken O'Flynn asked the Minister for Health whether a centralised national PrEP access register or demand-tracking system will be established. [36544/26]
TDs / Ken O'Flynn
Ken O'Flynn
Portrait: © Houses of the Oireachtas (Oireachtas (Open Data) PSI Licence) · source file
9,005
questions asked
Oral and written, to government departments
86,377
words spoken in the chamber
Across 393 contributions. Plus 40 contributions from the chair, not counted
295
votes recorded
Each Yes, No or Abstained in a recorded vote
421
topics asked about
Across 20 departments
From the Dáil chamber only: committee meetings are not in this archive.
What they ask about
The subject headings the Oireachtas filed their questions under.
Who they ask
The departments their questions were addressed to.
Month by month
Low months are usually recesses, when the Dáil does not sit. The archive runs to 22 October 2026.
Questions asked 9,005 in all
Dec 2024Oct 2026
Contributions to debates 393 in all
Dec 2024Oct 2026
Show as a table
| Month | Questions | Contributions |
|---|---|---|
| December 2024 | 0 | 1 |
| January 2025 | 0 | 1 |
| February 2025 | 17 | 20 |
| March 2025 | 14 | 22 |
| April 2025 | 24 | 16 |
| May 2025 | 227 | 18 |
| June 2025 | 49 | 14 |
| July 2025 | 35 | 24 |
| August 2025 | 0 | 0 |
| September 2025 | 663 | 33 |
| October 2025 | 297 | 9 |
| November 2025 | 1,060 | 18 |
| December 2025 | 621 | 2 |
| January 2026 | 190 | 45 |
| February 2026 | 911 | 14 |
| March 2026 | 387 | 38 |
| April 2026 | 691 | 31 |
| May 2026 | 2,122 | 20 |
| June 2026 | 635 | 22 |
| July 2026 | 289 | 11 |
| August 2026 | 0 | 2 |
| September 2026 | 347 | 12 |
| October 2026 | 426 | 20 |
Debates they spoke in most
Plus 188 contributions in the regular slots, such as Leaders' Questions and Priority Questions. Speech from the chair is not counted.
Asked about similar topics
Worked out by computer from the subject headings of each TD's questions, giving more weight to headings few TDs use. It shows shared subjects, not shared views.
Party, constituency and offices
- constituency Cork North-Central 29 November 2024 to now
- party Independent Ireland 29 November 2024 to now
Ken O'Flynn
Written
960. Deputy Ken O'Flynn asked the Minister for Health whether her Department has assessed the public-health risk arising where clinically eligible individuals cannot access PrEP within a clinically appropriate timeframe. [36545/26]
Ken O'Flynn
Written
961. Deputy Ken O'Flynn asked the Minister for Health the date by which the sexual health Model of Care will be completed; and whether it will include specific capacity targets, access standards, and reporting obligations for PrEP services. [36546/26]
Ken O'Flynn
Written
962. Deputy Ken O'Flynn asked the Minister for Health whether her Department will publish annual national data on PrEP access, including provider numbers, waiting times, regional capacity, expenditure and unmet demand. [36547/26]
Ken O'Flynn
Written
964. Deputy Ken O'Flynn asked the Minister for Health whether any internal HSE operational manual, assessment framework, decision-support document, checklist, or staff guidance exists for officials administering the Treatment Abroad Scheme beyond the EU Regulations themselves; and if so, if copies will be provided. [36560/26]
Ken O'Flynn
Written
965. Deputy Ken O'Flynn asked the Minister for Health whether officials administering the treatment abroad scheme are required to follow any standardised evidential criteria when assessing whether treatment is unavailable within the State or unavailable within a clinically appropriate timeframe. [36561/26]
Ken O'Flynn
Written
966. Deputy Ken O'Flynn asked the Minister for Health whether any audit, quality assurance, peer review, or consistency-review mechanism exists for treatment abroad scheme eligibility determinations; and if so, to provide details. [36562/26]
Ken O'Flynn
Written
967. Deputy Ken O'Flynn asked the Minister for Health whether any appeals, reconsideration, or secondary review process exists for applicants refused approval under the treatment abroad scheme; and if so, to provide details of the process and annual refusal figures since 2020. [36563/26]
Ken O'Flynn
Written
968. Deputy Ken O'Flynn asked the Minister for Health whether any category-specific governance arrangements apply to overseas referrals under the treatment abroad scheme involving gender-related healthcare interventions, including enhanced approval, audit, safeguarding, or specialist review requirements. [36564/26]
Ken O'Flynn
Written
969. Deputy Ken O'Flynn asked the Minister for Health the number of officials or clinical advisers currently involved in assessing treatment abroad scheme applications and whether any formal training programme or accreditation process applies to those making eligibility determinations. [36565/26]
Ken O'Flynn
Written
970. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any central database recording the clinical category, destination country, expenditure, approval rationale, and outcome of treatment abroad scheme referrals; and if not, whether the absence of such data has been identified as a governance risk. [36566/26]
Ken O'Flynn
Written
971. Deputy Ken O'Flynn asked the Minister for Health whether any procedures funded under the treatment abroad scheme are classified internally by the HSE as elective, quality-of-life enhancing, cosmetic, experimental, or non-urgent; and if she will provide the classification framework used. [36567/26]
Ken O'Flynn
Written
972. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any centralised register categorising treatment abroad scheme approvals by clinical urgency, specialty, or procedure type; and if she will provide details. [36568/26]
Ken O'Flynn
Written
973. Deputy Ken O'Flynn asked the Minister for Health whether any independent value-for-money review has ever been conducted specifically on the treatment abroad scheme; if so, to provide the dates and findings; and if not, why not. [36569/26]
Ken O'Flynn
Written
974. Deputy Ken O'Flynn asked the Minister for Health whether any national consistency review is carried out to assess whether similar clinical cases receive similar treatment abroad scheme approval outcomes across different hospitals or consultants. [36570/26]
Ken O'Flynn
Written
975. Deputy Ken O'Flynn asked the Minister for Health whether the Department has assessed the governance implications of approving overseas procedures in the absence of a nationally agreed definition of "medical necessity". [36571/26]
Ken O'Flynn
Written
976. Deputy Ken O'Flynn asked the Minister for Health whether her Department intends to establish a national classification framework distinguishing medically necessary procedures from elective or quality-of-life procedures for public funding purposes. [36572/26]
Ken O'Flynn
Written
977. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme is subject to any formal fraud-risk assessment, expenditure-risk scoring, or internal audit programme specific to high-cost referrals. [36573/26]
Ken O'Flynn
Written
978. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has carried out any benchmarking comparing the cost of overseas treatments funded under the treatment abroad scheme against equivalent domestic provision or alternative care pathways. [36575/26]
Ken O'Flynn
Written
979. Deputy Ken O'Flynn asked the Minister for Health whether any external clinical advisory body or independent review panel exists for disputed or high-cost treatment abroad scheme applications. [36576/26]
Ken O'Flynn
Written
980. Deputy Ken O'Flynn asked the Minister for Health whether the HSE or her Department maintains any database, framework, or internal assessment comparing the average cost of treatments funded under the treatment abroad scheme across different jurisdictions. [36578/26]
Ken O'Flynn
Written
981. Deputy Ken O'Flynn asked the Minister for Health whether any analysis has been carried out on whether equivalent procedures funded under the treatment abroad scheme could be accessed at lower cost in alternative jurisdictions within the EU, UK or Switzerland. [36579/26]
Ken O'Flynn
Written
982. Deputy Ken O'Flynn asked the Minister for Health whether any formal value-for-money methodology applies when approving treatment locations under the treatment abroad scheme. [36580/26]
Ken O'Flynn
Written
983. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive records the total reimbursement cost by treatment type and jurisdiction under the treatment abroad scheme. [36581/26]
Ken O'Flynn
Written
984. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, financial review, or governance assessment has examined variations in treatment abroad scheme reimbursement costs between jurisdictions for comparable procedures. [36582/26]